Dr. Jou, Yuh-Shan 周玉山 博士



  • EIF3C-enhanced exosome secretion promotes angiogenesis and tumorigenesis of human hepatocellular carcinoma
    Oncotarget, Jan 11, 2018
    Targeting tumor angiogenesis is a common strategy against human hepatocellular carcinoma (HCC). However, identification of molecular targets ......
    MORE 更多
  • Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis
    Oncotarget, Sep 08, 2017
    Cellular metabolism of cancer cell is generally recognized to provide energy for facilitating tumor growth, but little is known about the ab ......
    MORE 更多
  • Overexpressed-eIF3I interacted and activated oncogenic Akt1 is a theranostic target in human hepatocellular carcinoma.
    Hepatology., Mar 04, 2013
    Eukaryotic translation initiation factor 3 subunit I (eIF3I) with transforming capability is often overexpressed in human hepatocellular car ......
    MORE 更多
  • HDAC inhibitors augmented cell migration and metastasis through induction of PKCs leading to identification of low toxicity modalities for combination cancer therapy.
    Clin Cancer Res., Jul 18, 2012
    Histone deacetylase inhibitors (HDACi) are actively explored as new-generation epigenetic drugs but have low efficacy in cancer monotherapy. ......
    MORE 更多
  • IGDB.NSCLC: integrated genomic database of non-small cell lung cancer.
    Nucl. Acids Res, Dec 01, 2011
    Lung cancer is the most common cause of cancer-related mortality with more than 1.4 million deaths per year worldwide. To search for signifi ......
    MORE 更多

List of Highlights